Home › Non-Small Cell Lung Cancer › Michigan › Warren
Non-Small Cell Lung Cancer clinical trials in Warren, MI
4 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Warren (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Henry Ford Health Warren Hospital, Warren
- Henry Ford Madison Heights Hospital - Breast, Warren
- Henry Ford Warren Hospital - GLCMS, Warren
- and 4 more
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Henry Ford Health Warren Hospital, Warren
- Henry Ford Madison Heights Hospital - Breast, Warren
- Henry Ford Warren Hospital - GLCMS, Warren
- and 4 more
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RecruitingPhase 2
- Henry Ford Health Warren Hospital, Warren
- Henry Ford Madison Heights Hospital - Breast, Warren
- Henry Ford Warren Hospital - GLCMS, Warren
- and 3 more
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
RecruitingPhase 3
- Profound Research LLC - MHP MedOnc Royal Oak - Oakland Medical Group Location, Royal Oak · 7 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Other studies in Warren
- Breast Cancer9 studies
- Prostate Cancer7 studies
- Lung Cancer6 studies
- Colorectal Cancer5 studies
- Coronary Artery Disease5 studies
- Aortic Valve Stenosis4 studies
- Ovarian Cancer4 studies
- Multiple Myeloma4 studies
- Bladder Cancer4 studies
- Sjogren's Syndrome3 studies
- Post-COVID Conditions (Long COVID)3 studies
- Clostridium Infections3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.